1 – 10 of 659
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Health-Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab : Results From the Phase IV HemiNorth 2 Study
- Contribution to journal › Article
-
Mark
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder : Back to the clinical phenotype
- Contribution to journal › Article
-
Mark
Nya klassifikationskriterier för antifosfolipidsyndrom
- Contribution to journal › Article
-
Mark
Dronedarone vs Sotalol Among Patients With Atrial Fibrillation : A Meta-Analysis of Retrospective Observational Databases
- Contribution to journal › Article
-
Mark
Dronedarone provides effective early rhythm control : post-hoc analysis of the ATHENA trial using EAST-AFNET 4 criteria
- Contribution to journal › Article
-
Mark
Evaluation of kidney function and damage in patients with hemophilia B—insights from the B-Natural study
- Contribution to journal › Article
-
Mark
Haemophilia B : an illustrative review of current challenges and opportunities
- Contribution to journal › Article
-
Mark
Thrombotic risk determined by CREB3L1 variants in a population-based cohort study : linkage disequilibrium with prothrombin mutation
- Contribution to journal › Letter
-
Mark
Comorbidity and Mortality in Men and Women With Haemophilia in Three Nordic Countries–Comparisons to Matched Controls
- Contribution to journal › Article
-
Mark
A plain language summary on indirectly comparing bleeding after valoctocogene roxaparvovec gene therapy to bleeding with emicizumab prophylaxis
- Contribution to journal › Article
